119th Congress
H.R. 7050
Homeopathic Drug Product Safety, Quality, and Transparency Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Pete Sessions(R-TX)
- Introduced
- Jan 14, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (6)
Original cosponsors (2)
- Jonathan L. Jackson (D-IL)
- Mike Kennedy (R-UT)
Added later (4)
- Burgess Owens (R-UT) · Apr 21, 2026
- Cory Mills (R-FL) · May 20, 2026
- Michael Cloud (R-TX) · Jul 20, 2026
- Paul A. Gosar (R-AZ) · Jul 20, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes.
Latest action(Jan 14, 2026): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 14, 2026 · House
Referred to the House Committee on Energy and Commerce. - Jan 14, 2026
Introduced in House